Cargando…
P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429176/ http://dx.doi.org/10.1097/01.HS9.0000969056.80196.f1 |
| _version_ | 1785090645363261440 |
|---|---|
| author | Marconi, Giovanni Arslan, Shukaib Fleming, Shaun Curti, Antonio S Blachly, James Martinelli, Giovanni Giovanni Della Porta, Matteo Bajel, Ashish Sauer, Tim Crysandt, Martina Pigneux, Arnaud Konopleva, Marina Marmor, Yotvat Sharma, Shringi Elgeioushi, Nairouz Rowe, Emily Cheung, Patricia Jahn, Ekaterina Saeh, Jamal Tibes, Raoul Zumla Cader, Fathima Jain, Nitin |
| author_facet | Marconi, Giovanni Arslan, Shukaib Fleming, Shaun Curti, Antonio S Blachly, James Martinelli, Giovanni Giovanni Della Porta, Matteo Bajel, Ashish Sauer, Tim Crysandt, Martina Pigneux, Arnaud Konopleva, Marina Marmor, Yotvat Sharma, Shringi Elgeioushi, Nairouz Rowe, Emily Cheung, Patricia Jahn, Ekaterina Saeh, Jamal Tibes, Raoul Zumla Cader, Fathima Jain, Nitin |
| author_sort | Marconi, Giovanni |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429176 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104291762023-08-17 P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL Marconi, Giovanni Arslan, Shukaib Fleming, Shaun Curti, Antonio S Blachly, James Martinelli, Giovanni Giovanni Della Porta, Matteo Bajel, Ashish Sauer, Tim Crysandt, Martina Pigneux, Arnaud Konopleva, Marina Marmor, Yotvat Sharma, Shringi Elgeioushi, Nairouz Rowe, Emily Cheung, Patricia Jahn, Ekaterina Saeh, Jamal Tibes, Raoul Zumla Cader, Fathima Jain, Nitin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429176/ http://dx.doi.org/10.1097/01.HS9.0000969056.80196.f1 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Marconi, Giovanni Arslan, Shukaib Fleming, Shaun Curti, Antonio S Blachly, James Martinelli, Giovanni Giovanni Della Porta, Matteo Bajel, Ashish Sauer, Tim Crysandt, Martina Pigneux, Arnaud Konopleva, Marina Marmor, Yotvat Sharma, Shringi Elgeioushi, Nairouz Rowe, Emily Cheung, Patricia Jahn, Ekaterina Saeh, Jamal Tibes, Raoul Zumla Cader, Fathima Jain, Nitin P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL |
| title | P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL |
| title_full | P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL |
| title_fullStr | P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL |
| title_full_unstemmed | P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL |
| title_short | P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL |
| title_sort | p537: safety and tolerability of azd0466 as monotherapy for patients with advanced hematological malignancies - preliminary results from an ongoing phase i/ii trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429176/ http://dx.doi.org/10.1097/01.HS9.0000969056.80196.f1 |
| work_keys_str_mv | AT marconigiovanni p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT arslanshukaib p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT flemingshaun p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT curtiantonio p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT sblachlyjames p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT martinelligiovanni p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT giovannidellaportamatteo p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT bajelashish p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT sauertim p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT crysandtmartina p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT pigneuxarnaud p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT konoplevamarina p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT marmoryotvat p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT sharmashringi p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT elgeioushinairouz p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT roweemily p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT cheungpatricia p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT jahnekaterina p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT saehjamal p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT tibesraoul p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT zumlacaderfathima p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial AT jainnitin p537safetyandtolerabilityofazd0466asmonotherapyforpatientswithadvancedhematologicalmalignanciespreliminaryresultsfromanongoingphaseiiitrial |